Printer Friendly

9 Healthcare Stocks Moving In Thursday's Pre-Market Session.

Byline: Lisa Levin

Gainers

* SELLAS Life Sciences, Inc. (NASDAQ: SLS) stock moved upwards by 8.2% to $0.15 during Thursday's pre-market session. The market cap seems to be at $27.0 million.

* InMode, Inc. (NASDAQ: INMD) shares surged 3.0% to $26.03.

* Livongo Health, Inc. (NASDAQ: LVGO) shares rose 2.0% to $31.50. The market cap seems to be at $4.0 billion. The most recent rating by Morgan Stanley, on August 28, is at Overweight, with a price target of $42.00.

* CVS Health, Inc. (NYSE:CVS) stock surged 1.8% to $62.75. The market cap seems to be at $56.8 billion. The most recent rating by Cowen & Co., on August 27, is at Outperform, with a price target of $76.00.

* Addus HomeCare, Inc. (NASDAQ: ADUS) shares increased by 1.3% to $80.60. The market cap stands at $789.5 million. The most recent rating by Raymond James, on August 07, is at Outperform, with a price target of $92.00.

Losers

* Mallinckrodt, Inc. (NYSE:MNK) stock plummeted 41.1% to $1.53 during Thursday's pre-market session. According to the most recent rating by BMO Capital, on September 05, the current rating is at Market Perform.

* Endo International, Inc. (NASDAQ: ENDP) shares fell 10.7% to $2.18. The market cap stands at $644.6 million. The most recent rating by Morgan Stanley, on July 15, is at Underweight, with a price target of $3.00.

* Teva Pharmaceutical Indus, Inc. (NYSE:TEVA) stock plummeted 3.4% to $6.85. The market cap stands at $7.3 billion. The most recent rating by BMO Capital, on August 09, is at Market Perform, with a price target of $9.00.

* Grifols, Inc. (NASDAQ: GRFS) shares declined 1.0% to $20.98. The market cap stands at $14.1 billion. The most recent rating by JP Morgan, on June 27, is at Overweight, with a price target of $22.50.

(c) 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

COPYRIGHT 2019 Accretive Capital LLC dba Benzinga.com
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Benzinga.com
Date:Sep 5, 2019
Words:413
Previous Article:The Daily Biotech Pulse: Cheery Results For Sage's Depression Drug, UniQure Offering, Axsome Aces Study Of Headache Drug.
Next Article:Kirkland's Falls 25% On Q2 Earnings Miss Due To Shift In Consumer Purchasing Behavior.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |